SCHEMBL29124352

SCHEMBL29124352

COc1cnc(N[C@H]2CCN(C(=O)OC(C)(C)C)C2)c(N)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.56
ALDH1A1 P00352 1/20 0.52
BTK Q06187 1/20 0.49
PIK3CA P42336 1/20 0.47
USP30 Q70CQ3 6/20 0.47
NSD2 O96028 1/20 0.45
ADORA1 P30542 1/20 0.44
RIPK1 Q13546 1/20 0.43
SRC P12931 2/20 0.43
DYRK1A Q13627 1/20 0.42
ABL1 P00519 1/20 0.42
EGFR P00533 1/20 0.42
ABL2 P42684 1/20 0.42
CTSD P07339 1/20 0.42
CTSE P14091 1/20 0.42
BACE1 P56817 1/20 0.42
GPR119 Q8TDV5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31170947 1.00 PIK3CD (0.56) PIK3CDALDH1A1BTKPIK3CAUSP30
SCHEMBL29124354 1.00 PIK3CD (0.56) PIK3CDALDH1A1BTKPIK3CAUSP30
SCHEMBL29124357 0.88 PIK3CD (0.53) PIK3CDALDH1A1BTKPIK3CAUSP30
SCHEMBL29124358 0.88 PIK3CD (0.53) PIK3CDALDH1A1BTKPIK3CAUSP30
SCHEMBL31170908 0.88 PIK3CD (0.53) PIK3CDALDH1A1BTKPIK3CAUSP30
SCHEMBL2636499 0.87 PIK3CD (0.52) PIK3CDALDH1A1BTKPIK3CAUSP30
SCHEMBL2636502 0.87 PIK3CD (0.52) PIK3CDALDH1A1BTKPIK3CAUSP30
SCHEMBL23236320 0.86 EGFR (0.43) PIK3CDBTKPIK3CAEGFR
SCHEMBL23236321 0.86 EGFR (0.43) PIK3CDBTKPIK3CAEGFR
SCHEMBL7178416 0.85 PIK3CD (0.51) PIK3CDBTKPIK3CAUSP30ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112689637-B Imidazopyridone compounds 橘生药品工业株式会社 2023-11-10 CN disclosed
CN-112689637-A Imidazopyridinone compounds 橘生药品工业株式会社 2021-04-20 CN disclosed